![]()
Arcus Biosciences (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer and immune diseases, announced that its management team will participate in the following upcoming investor conferences in December:
8th Annual Evercore Healthcare Conference
Date: Tuesday, December 1st, 2026
Location: Coral Gables, FL
Format: Fireside chat & 1×1 meetings
Time: 3:50 p.m. ET
Citi’s 2026 Global Healthcare Conference
Date: Wednesday, December 2nd, 2026
Location: Miami, FL
Format: Fireside chat & 1×1 meetings
Time: 2:20 p.m. ET
Live webcasts of the fireside chats will be available by visiting the “Investors & Media” section of the Arcus Biosciences website at www.arcusbio.com. Replays will be available following the live event.
About Arcus Biosciences
Arcus Biosciences is a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for the treatment of cancer and immune diseases. Founded in 2015, Arcus pairs proven biology with exceptional chemistry to create medicines that deliver meaningful improvements for patients. The company has advanced two oncology programs to Phase 3 clinical trials, including casdatifan, a HIF-2α inhibitor for clear cell renal cell carcinoma, and quemliclustat, a small-molecule CD73 inhibitor for pancreatic cancer. Arcus is also applying its small-molecule, medicinal chemistry and antibody capabilities to expand into immunology. Every program is held to the highest standard: outperform the current standard of care. For more information about Arcus Biosciences’ clinical and preclinical programs, please visit www.arcusbio.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20261118572847/en/
Media gallery